Risk Stratification in Multiple Myeloma: Putting the Pieces Together

November 7, 2015

Learning Objectives

  • Describe updated recommendations for the diagnosis and risk-stratified treatment of Multiple Myeloma (MM)
  • Discuss new novel agents for the treatment of MM including indications, common adverse events, monitoring and support of the patient receiving these treatments
  • Implement effective clinical strategies for minimizing toxicity
  • Utilize practical strategies for enhancing patients’ adherence to treatment
Course summary
Available credit: 
  • 1.00 AANP
  • 0.67 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC
Course opens: 
11/07/2015
Course expires: 
02/29/2016
Event starts: 
11/07/2015 - 1:30pm
Event ends: 
11/07/2015 - 2:30pm
Cost:
$0.00
Parent activity set: 
Concurrent Sessions 1:30-2:30PM
Add to calendar: 
Rating: 
0
United States

Craig B. Reeder, MD
Angela Mayo, PA

Available Credit

  • 1.00 AANP
  • 0.67 Pharmacology
  • 1.00 ACPE
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Attendance
  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.